Good pseudoaccommodation with MICS lens at one year

Article

The new MICS lens (Ioltech-Zeiss) is appropriate for the correction of intermediate vision in pseudophakia, according to Carlos Verges, Jorge Cazal and Marc Menezo of the Department of Ophthalmology, Institut Universitari Dexeus, Barcelona, Spain.

The new MICS lens (Ioltech-Zeiss) is appropriate for the correction of intermediate vision in pseudophakia, according to Carlos Verges, Jorge Cazal and Marc Menezo of the Department of Ophthalmology, Institut Universitari Dexeus, Barcelona, Spain.

The researchers presented the clinical results after one-year experience using the MICS lens. A total of 48 consecutive cataractous patients underwent MICS bimanual surgery and implantation of the lens using an incision of just 1.8 mm. The total diameter of the lens is just 12 mm allowing it to be positioned farther into the posterior plane than usual; 5.5 to 6 mm from the corneal endothelium at the nodal plane. The MTF, in the laboratory, was 92 changing to 80 with tilting conditions of 8º and decentration of 0.5 mm.

The results showed that, at one-year follow-up, 92% of subjects had an uncorrected distance visual acuity (UCDVA) of 20/25 and 96% a best corrected distance visual acuity (BCDVA) >20/25. 65% of patients achieved J3 with distance correction and 98% achieved J5. Two subjects required YAG laser for posterior capsule opacification (PCO) and two showed a folded haptic due to capsular retraction, not affecting vision or lens position. Three subjects reported glistening signs but vision was not affected.

Verges and his co-workers believe that the ability to position the lens at the level of the nodal planes combined with the lens' optical geometry allowing a pseudoaccommodative effect, makes the MICS lens appropriate for correct intermediate vision in pseudophakia.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.